← Back to Patent Explorer
US4803216A Expired / Lapsed US ⏱️ 0.0 years remaining

Pyrazole-3-amines as anti-inflammatory agents

Assignee: Fisons Ltd
•
Filing: 1987-05-05
•
Granted: 1989-02-07
•
Expires: 2007-05-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are described compounds of formula I, ##STR1## in which R 1 represents hydrogen, alkyl, alkanoyl or alkyl substituted by Ar 1 , R 3 , R 4 and R 5 , which may be the same or different, each independently represent hydrogen, alkyl or Ar 3 , Ar 1 , Ar 2 and Ar 3 , which may be the same or different, independently represent phenyl or phenyl substituted by one or more of alkyl, hydroxy, alkoxy, NR 6 R 7 or halogen, R 6 and R 7 , which may be the same or different, independently represent hydrogen or alkyl, and pharmaceutically acceptable acid addition salts thereof. Compositions containing the compounds and methods for their preparation are also described. The compounds are indicated for use as pharmaceutical, e.g. anti-inflammatory, agents.

Inventors

  • 👤 Richard A. Appleton
  • 👤 John Dixon
  • 👤 Sidney C. Burford

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 04:19
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/14; C07D231/38

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 221 words
A compound having the formula ##STR9## in which R 1 represents hydrogen, alkyl, alkanoyl or alkyl substituted by Ar 1 , R 3 , R 4 and R 5 , which may be the same or different, each independently represent hydrogen, alkyl or Ar 3 , Ar 1 , Ar 2 and Ar 3 , which may be the same or different, independently represent phenyl or phenyl substituted by one or more of alkyl, hydroxy, alkoxy, NR 6 R 7 or halogen, R 6 and R 7 , which may be the same or different, independently represent hydrogen or alkyl, provided that (i) when R 1 , R 3 and R 4 each represent hydrogen, and R 5 represents methyl, then Ar 2 does not represent phenyl or phenyl substituted by alkyl, alkoxy or halaogen and (ii) when R 1 , R 3 and R 4 each represent hydrogen and AR 2 represents phenyl or phenyl substituted by alkyl, then R 5 does not represent phenyl or phenyl substituted by alkyl, alkoxy or halogen, and (iii) when R 1 and R 3 represent hydrogen, and Ar 2 represents pheyl, then, (a) R 4 and R 5 do not both represent phenyl and (b) R 5 does not represent hydrogen when R 4 represents alkyl, and pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 221 words
A compound having the formula ##STR9## in which R 1 represents hydrogen, alkyl, alkanoyl or alkyl substituted by Ar 1 , R 3 , R 4 and R 5 , which may be the same or different, each independently represent hydrogen, alkyl or Ar 3 , Ar 1 , Ar 2 and Ar 3 , which may be the same or different, independently represent phenyl or phenyl substituted by one or more of alkyl, hydroxy, alkoxy, NR 6 R 7 or halogen, R 6 and R 7 , which may be the same or different, independently represent hydrogen or alkyl, provided that (i) when R 1 , R 3 and R 4 each represent hydrogen, and R 5 represents methyl, then Ar 2 does not represent phenyl or phenyl substituted by alkyl, alkoxy or halaogen and (ii) when R 1 , R 3 and R 4 each represent hydrogen and AR 2 represents phenyl or phenyl substituted by alkyl, then R 5 does not represent phenyl or phenyl substituted by alkyl, alkoxy or halogen, and (iii) when R 1 and R 3 represent hydrogen, and Ar 2 represents pheyl, then, (a) R 4 and R 5 do not both represent phenyl and (b) R 5 does not represent hydrogen when R 4 represents alkyl, and pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 18 words
A compound according to claim 1, in which R 1 represents hydrogen, CH 2 Ar 1 or alkyl.
Claim 4
Dependent Claim 20 words
A compound according to claim 1, in which Ar 2 is phenyl substituted by an OH, alkoxy or dialkylamino group.
Claim 5
Dependent Claim 12 words
A compound according to claim 1, in which Ar 2 represents hydroxyphenyl.
Claim 6
Dependent Claim 16 words
A compound according to claim 1, in which R 5 represents hydrogen or Ar 3 .
Claim 7
Dependent Claim 17 words
A compound according to claim 1, which is 4-(5-Phenyl-1H-pyrazol-3-yl)aminophenol or a pharmaceutically acceptable acid addition salt thereof.
Claim 8
Dependent Claim 23 words
A compound according to claim 1, which is 4-(1-Phenylmethyl-1H-pyrazol-3-yl) aminophenol, 2-(1H-Pyrazol-3-yl)aminophenol, 2-(1-Methyl-1H-pyrazol-3-yl)aminophenol, or a pharmaceutically acceptable acid addition salt of any one thereof.
Claim 9
Dependent Claim 35 words
A compound according to claim 1, which is: N-(4-methoxyphenyl)-3(5)-phenyl-1H-pyrazol-5(3)-amine, 1-Acetyl-N-[4-methoxyphenyl]-1H-pyrazol-3-amine, N-[4-Methoxyphenyl]-1-phenylmethyl-1H-pyrazol-3-amine, N-[4-Methoxyphenyl]-1-[1-methyl]ethyl-1H-pyrazol-3-amine, N-[4-Methoxyphenyl]-1-methyl-1H-pyrazol-3-amine, 5-Methyl-N-phenyl-1-phenylmethyl-1H-pyrazol-3-amine, N-[4-Methoxyphenyl]-1H-pyrazol-3-amine, 5-Methyl-N-phenyl-1H-pyrazole-3-amine, N-[4-Methoxyphenyl]-5-methyl-1H-pyrazol-3-amine, N-[4-Methoxyphenyl]-1-methyl-5-phenyl-1H-pyrazol-3-amine, N-[4-Methoxyphenyl]-4,5-diphenyl-1H-pyrazol-3-amine, 4-[3-(4-Methoxyphenylamino)-1H-pyrazol-5-yl]phenol, N-(4-Hydroxyphenyl)-1H-pyrazol-3-amine, 4-(1-Methylpyrazol-3-yl)aminophenol, 1-Methyl-N-(4-dimethylaminophenyl)-1H-pyrazol-3-amino, 4-(1-(4-Methoxyphenyl)methylpyrazol-3-yl)aminophenol, or a pharmaceutically acceptable acid addition salt of any one thereof.
Claim 10
Dependent Claim 30 words
A method of treatment of an inflammatory condition, which comprises administration of an effective amount of a compound according to claim 1 to a patient suffering from such a condition.
Claim 11
Dependent Claim 29 words
A pharmaceutical composition for treating an inflammatory condition comprising an effective amount of a compound according to claim 1 in association with a pharmaceutically acceptable carrier, diluent, or adjuvant.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-02-07 1992-08-08 1993-02-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-02-07 1996-08-08 1997-02-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-02-07 2000-08-08 2001-02-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag